Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NORTHWELL HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1997-01-01

Employees: -

Market Cap: -

Website: https://www.northwell.edu/

Clinical Trials

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Conditions: Neuroendocrine Tumors

First Posted Date: 2015-03-02

Last Posted Date: 2016-11-08

Lead Sponsor: Northwell Health

Registration Number: NCT02375464

Improving Care and Reducing Cost Study

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Psychosis NOS

Interventions: Behavioral: Relapse Prevention Plan
Behavioral: Daily Support Website
Behavioral: Computer CBT for voices and paranoia
Behavioral: FOCUS
Other: Prescriber Decision Assistant

First Posted Date: 2015-02-18

Last Posted Date: 2017-03-23

Lead Sponsor: Northwell Health

Target Recruit Count: 461

Registration Number: NCT02364544

Locations: 🇺🇸
Henderson Mental Health Center, Ft Lauderdale, Florida, United States
🇺🇸
Community Mental Health Center, Inc., Lawrenceburg, Indiana, United States
🇺🇸
Cherry Street, Grand Rapids, Michigan, United States

and more 5 locations

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

Phase 4

Terminated

Conditions: Attenuated Psychosis Syndrome

Interventions: Drug: Aripiprazole
Drug: Fluoxetine

First Posted Date: 2015-02-06

Last Posted Date: 2023-11-15

Lead Sponsor: Northwell Health

Target Recruit Count: 9

Registration Number: NCT02357849

Locations: 🇺🇸
The Zucker Hillside Hospital, Glen Oaks, New York, United States

Adjunctive Vortioxetine in Schizophrenia

Phase 4

Active, not recruiting

Conditions: Schizophrenia
Negative Symptoms

Interventions: Drug: Vortioxetine
Other: Placebo

First Posted Date: 2015-02-06

Last Posted Date: 2024-02-08

Lead Sponsor: Northwell Health

Target Recruit Count: 88

Registration Number: NCT02357797

Locations: 🇺🇸
Henderson Behavioral Health, Lauderdale Lakes, Florida, United States
🇺🇸
Cherry Health, Grand Rapids, Michigan, United States
🇺🇸
The Zucker Hillside Hospital, Glen Oaks, New York, United States

Belimumab in Idiopathic Inflammatory Myositis

Phase 2

Completed

Conditions: Myositis

Interventions: Drug: Belimumab
Drug: Placebo

First Posted Date: 2015-01-28

Last Posted Date: 2024-02-09

Lead Sponsor: Northwell Health

Target Recruit Count: 17

Registration Number: NCT02347891

Locations: 🇺🇸
Northwell Health Divison of Rheumatology, Great Neck, New York, United States

Vaginal Creams to Reduce Vaginal Erosion in Pessary Users

Phase 2

Withdrawn

Conditions: Atrophy of Vagina
Vaginal Ulceration
Vaginitis

Interventions: Drug: Estradiol
Other: placebo

First Posted Date: 2014-12-12

Last Posted Date: 2015-10-02

Lead Sponsor: Northwell Health

Registration Number: NCT02316249

Locations: 🇺🇸
Division of Urogynecology North Shore-LIJ School of Medicine, Great Neck, New York, United States

Pleth Variability and Asthma Severity in Children

Completed

Conditions: Status Asthmaticus

First Posted Date: 2014-11-26

Last Posted Date: 2016-07-26

Lead Sponsor: Northwell Health

Target Recruit Count: 37

Registration Number: NCT02302261

Locations: 🇺🇸
Cohen Children's Medical Center of NY, New Hyde Park, New York, United States

NSAIDs for Pain After Ankle Fracture Surgery

Phase 4

Withdrawn

Conditions: Closed Fracture of Ankle

Interventions: Drug: Placebo
Drug: Naproxen

First Posted Date: 2014-11-04

Last Posted Date: 2015-12-18

Lead Sponsor: Northwell Health

Registration Number: NCT02281968

Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery

Phase 4

Completed

Conditions: Post-operative Pain

Interventions: Drug: Liposome Bupivacaine
Drug: Bupivacaine HCl

First Posted Date: 2014-10-24

Last Posted Date: 2018-06-14

Lead Sponsor: Northwell Health

Target Recruit Count: 65

Registration Number: NCT02274870

Locations: 🇺🇸
Franklin, Valley Stream, New York, United States

Evaluating Anodal tDCS Preceding Aphasia Therapy

Phase 1

Terminated

Conditions: Stroke
Aphasia

Interventions: Device: transcranial direct current stimulation

First Posted Date: 2014-09-26

Last Posted Date: 2021-04-05

Lead Sponsor: Northwell Health

Target Recruit Count: 15

Registration Number: NCT02249819

Locations: 🇺🇸
Feinstein Institute for Medical Research, Manhasset, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy